#PrecisionMedicine #CDDFworkshop; need to get patients involved

Athanasios reporting back on our breakout session that discussed trial data, which data are important and why from different stakeholder perspectives #CDDFworkshop

RT cancereu "How do patients know what they don't know? How do patients know what they would #prefer? kgapo answers the question at #CDDFworkshop #CancerPatients #biomarkers https://t.co/dfZAiPrYH8"

ECPC President, Francesco de Lorenzo, speaking on #genomics in cancer at #CDDFworkshop today. Bringing the patient perspective to the panel on #PersonalisedMedicine - The Future of Drug Development #biomarkers

RT cancereu "ECPC President, Francesco de Lorenzo, speaking on #genomics in cancer at #CDDFworkshop today. Bringing the patient perspective to the panel on #PersonalisedMedicine - The Future of Drug Development #biomarkers https://t.co/1fKnensy4s"

Currently running the #multistakeholder #CDDFworkshop on #biomarkers & #patients #access to #personalized #oncology #drugs in #Europe 💪🏼 #cancerdrugs #development @cddf_eu #event #conference #management #brussels #belgium

Power tweeting the tweet of tweet as thank you to ⁦⁦⁦@cddf_eu⁩ & ideas @ #CDDFworkshop enabling to understand data from lab to living room in order to ensure sustainable cancer care. Let’s stay connected and see you soon. #weallcan ⁦@AllCanGroup⁩

Da Volterra attending CDDF multi-Stakeholder workshop on Impact of the #Microbiome on Cancer Growth and Therapy, in Munich on February 15-16, 2019. #CDDFworkshop https://t.co/JhByyfT5wg

Find a new event at The #Microbiome Portal: CDDF multi-Stakeholder workshop on Impact of the Microbiome on Cancer Growth and Therapy @cddf_eu #CDDFworkshop https://t.co/BOJYbQHI05

Last meeting of the year 💪🏼 #CDDFworkshop on #MRD #AML #CLL in London #UK #eventmanagement #healthcare #multistakeholder #meetings #workshops #collaborationiskey

How do patients know what they don't know? How do patients know what they would #prefer? @kgapo answers the question at #CDDFworkshop #CancerPatients #biomarkers

RT cancereu "RT cddf_eu: Discover the advance #programme of upcoming #CDDFworkshop on #biomarkers and #patient's access to #personalized #oncology #drugs in #Europe Register online on https://t.co/rAhOLu4Nxv #Brussels #Belgium https://t.co/kg2BoykxGu"

Join Third CDDF(1) Multi-stakeholder workshop on Minimal Residual Disease : AML and CLL will focus on the current status and next steps for the use MRD in AML and CLL clinical trial. #cddfworkshop @cddf_eu

🎙The last panel discussion at #CDDFWorkshop together with the experts in the field: Nathalie Bere (EMA), Dónal Landers (Digital ECMT), Leanna Goodwin (Digital ECMT), Leanne Philips (Digital ECMT), Petra Wilson(Health Connect Partners) & Mark Lawler (Queen’s University Belfast).

@cddf_eu workshop on Patient Access & Engagement in Oncology Drug Development is now over. Together we examined ways in which patients can be empowered to be active participants in cancer research. 👏Thank you all for being part of this! #patients #CancerResearch #cddfworkshop

🎙️#Livenow: Leanne Philips (Manchester Foundation Trust / digital ECMT) is giving a presentation on the unmet clinical needs relating to patients who have cancer and kidney problems. #CDDFWorkshop #inhomestudy #cancerpatients #kidneydisease #oncologyresearch

🎙️#Livenow: Leanna Goodwin from digital Experimental Cancer Medicine Team is speaking at #CDDFWorkshop about engaging with patients throughout the process of developing, designing and conducting Technology Clinical Trials. #digitalhealth #oncology #CDDF

@cddf_eu #CDDFworkshop @cancereu @AllCanGroup #weallcan #Biomarkers I look forward to talking about the need for multistakeholder collaborations and efficient use of data in order to realise precision medicine dream for patients in need

EMA approval is not access! Patients are hostage in a negotiation dialogue between industry and governments. @StefanGijssels shared a #Patient Perspective on #earlyaccess . #cddfworkshop #cddf_eu

#Livenow: Panel discussion of Session 3, chaired by Kim H. Lyerly (AAADV, US) & John Smyth (CDDF, UK). Which 3 aspects did you like most of this CDDF Annual Meeting? Let us know here below #live #paneldiscussion #cddfworkshop